5-amino-1-phenyl-2,3-dihydro-1H-pyrazol-3-one, 97%, 1g

tert-Butyl octahydro-4H-pyrido[4,3-b][1,4]oxazine-4-carboxylate, 98%, 1g

2,4,6-Trinitrobenzenesulfonic acid (1% in DMF), 95.0%, 50ml

DL-Homocystine, 95.0%, 25g

1-(4-AMINOPHENYL)PYRROLIDIN-2-ONE HCL, 95.0%, 5g

6-Chloro-3-hydroxypyrazine-2-carboxamide, 95.0%, 1g

6-FLUORO-3-IODO-1-METHYL-1H-INDAZOLE, 95.0%, 250mg

tert-butyl N-[(2-methylpropan-2-yl)oxycarbonyl]-N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl]carbamate, 95%, 250mg

Ácido metanosulfónico, 70%, para síntesis, 100 ml, envase de vidrio

Diphenyliodonium iodide, 95%, 100g

1-PHENYL-1H-IMIDAZOLE-4,5-DICARBOXYLIC ACID HCL, 90.0%, 250mg

N-Fmoc-3-hydroxy-D-phenylalanine, 97%, 250mg

(2S,3R,4S,5S)-5-((R)-1-Azido-2-(pivaloyloxy)ethyl)tetrahydrofuran-2,3,4-triyl tris(2,2-dimethylpropanoate), 98%, 10mg